Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Novel targets for AML

Ramiro Garzon • 5 Oct 2017
ESH 2017
Acute Myeloid Leukemia

There are currently a number of ongoing clinical trials for acute myeloid leukemia (AML) that are targeting nuclear exporters. In this video, recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ramiro Garzon, MD, from Ohio State University, Columbus, OH, discusses the promise of these novel agents.

More from Ramiro Garzon

1:10
Targeting non-coding RNAs in leukemia
Ramiro Garzon • 5 Oct 2017
2:12
Exportin (XPO1) inhibitors for the treatment of AML
Ramiro Garzon • 5 Oct 2017

Related Videos

3:34
Total marrow and lymphoid irradiation plus cyclophosphamide & etoposide in poor-risk acute leukemias
Anthony Stein • 15 Apr 2024
2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
2:05
Investigating mutation order in AML using single-cell sequencing
Ravindra Majeti • 8 Apr 2024
3:12
An epitope editing approach to enable the use of targeted immunotherapy in AML
Gabriele Casirati • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals